USFDA issues Form 483 with three observations to Lupin's Somerset, New Jersey facility after inspection. Lupin will respond to USFDA.

Lupin settles US antitrust lawsuits for $30 million with Humana, denies wrongdoing, and aims to avoid prolonged legal costs ...

(Dilip Shanghvi, the reticent founder of Sun Pharmaceuticals, the largest pharmaceuticals company in India, is younger, so is ...

Lupin said the US drug regulator issued the same after concluding its inspection, which was conducted from April 13 to April ...

Lupin said that the United States Food and Drug Administration (U.S. FDA) has concluded an inspection at our manufacturing facility located in Somerset, New Jersey, U.S.A.

Lupin receives USFDA Form 483 with three observations after inspection of its New Jersey facility, says it will address ...

New Delhi, Apr 18 (PTI) Pharma major Lupin Ltd on Saturday said the US health regulator has issued Form 483 with three observations to its Somerset, New Jersey, facility in the US following an ...

Lupin's US arm settles antitrust litigation with Humana Inc. for USD 30 million to avoid further costs and uncertainties.

Investing.com-- Lupin’s (NSE: LUPN ) U.S. unit settled an antitrust lawsuit with insurer Humana Inc (NYSE: HUM) for $30 ...

Pharma major Lupin Ltd on Friday said its arm Lupin Pharmaceuticals, Inc USA has entered into a USD 30 million settlement ...